Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONCY share buyback?

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron Mar 11, 2023 10:16am

115 Views

Post# 35332413

RE:ONCY share buyback?

The capital is perhaps more useful at ONC/ONCY than in their stock. Canadian banks blew 19.7 billion at SVB. Let us hope we have no exposure.

I do not think it is unreasonable to assume that the recent selloff is at least partially attributable to SVB. In fact quite likely.

Holding strong.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market